JANE STREET GROUP, LLC - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$10,000
-82.1%
23,784
-64.0%
0.00%
Q2 2022$56,000
-73.1%
66,129
+75.1%
0.00%
Q1 2022$208,000
-22.4%
37,765
+151.8%
0.00%
Q3 2021$268,000
-78.2%
15,000
-70.2%
0.00%
Q2 2021$1,228,000
-65.7%
50,300
-62.7%
0.00%
-100.0%
Q1 2021$3,578,000
+4210.8%
135,028
+1130.1%
0.00%
Q4 2020$83,000
-46.1%
10,977
-64.2%
0.00%
Q3 2020$154,00030,6420.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,506,526$6,546,1090.21%
HARBOURVEST PARTNERS LLC 986,878$172,7040.06%
Artal Group S.A. 2,042,666$3570.02%
Virtu Financial LLC 68,825$120.00%
ACADIAN ASSET MANAGEMENT LLC 1,277,196$2220.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$110,1440.00%
Baillie Gifford 4,869,126$837,9770.00%
Citadel Advisors 600$1030.00%
Tower Research Capital LLC (TRC) 25$00.00%
JPMORGAN CHASE & CO 2,196$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders